COVID-19 and Immune System Impacts, Source Citations

Slide 2:

Slide 3:

NIH, Severe COVID-19 May Cause Long-Term Immune System Changes https://covid19.nih.gov/news-and-stories/severe-covid-19-may-cause-long-term-immune-system-changes
Memorial Sloan Kettering Cancer Center Library, COVID Impacts https://libguides.mskcc.org/CovidImpacts/Immune
Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes https://www.pnas.org/doi/10.1073/pnas.2300644120
Nature Immunology, Immune dysregulation in long COVID https://www.nature.com/articles/s41590-024-01795-z
Nature Immunology, Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection https://www.nature.com/articles/s41590-021-01113-x
Nature Immunology, Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 https://www.nature.com/articles/s41590-023-01724-6
Nature, Distinguishing features of long COVID identified through immune profiling https://pubmed.ncbi.nlm.nih.gov/37748514/
Cell, Multiple early factors anticipate post-acute COVID-19 sequelae https://pubmed.ncbi.nlm.nih.gov/35216672/
eClinical Medicine, Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study

Slide 4:

Slide 5:

Statistics Canada, Experiences of Canadians with long-term symptoms following COVID-19 https://www150.statcan.gc.ca/n1/pub/75-006-x/2023001/article/00015-eng.htm
NPJ Vaccines, Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome https://www.nature.com/articles/s41541-023-00739-2
Int. Journal of Molecular Science, SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454552/
Nature Medicine, Acute and postacute sequelae associated with SARS-CoV-2 reinfection https://www.nature.com/articles/s41591-022-02051-3

Slide 6:

eClinical Medicine (The Lancet), Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00331-0/fulltext
Nature Reviews Rheumatology, High risk of autoimmune diseases after COVID-19 https://www.nature.com/articles/s41584-023-00964-y
Cedars-Sinai, COVID-19 Can Trigger Self-Attacking Antibodies https://www.cedars-sinai.org/newsroom/covid-19-can-trigger-self-attacking-antibodies/
Journal of Translational Medicine, Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-03184-8
Clinical Rheumatology, COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450255/

Slide 7:

Family Medicine and Community Health (BMJ), Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0–5 years in the USA in 2022: a multicentre retrospective cohort study https://fmch.bmj.com/content/11/4/e002456
Frontiers in Immunology, Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.949787/full
Nature, Distinguishing features of long COVID identified through immune profiling https://pubmed.ncbi.nlm.nih.gov/37748514/
Cell, Multiple early factors anticipate post-acute COVID-19 sequelae https://pubmed.ncbi.nlm.nih.gov/35216672/

Slide 8:

The Lancet Regional Health, Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023 https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00038-3/fulltext
CDC, Covid-19, Ventilation in Buildings https://www.cdc.gov/coronavirus/2019-ncov/community/ventilation.html

Slide 9: